You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Diabetes and other endocrinal, nutritional and metabolic conditions
  5. Obesity

Naltrexone–bupropion for managing overweight and obesity

  • Technology appraisal guidance
  • Reference number: TA494
  • Published:  12 December 2017
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History
Download guidance (PDF)
  • Overview
  • 1 Recommendations
  • 2 The technology
  • 3 Committee discussion
  • 4 Appraisal committee members and NICE project team
  • Update information

Update information

Minor changes since publication

March 2025: Links were updated following publication of NICE's guideline on overweight and obesity management.

ISBN: 978-1-4731-2649-7


Previous page 4 Appraisal committee members and NICE project team
Back to top